Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Zhuhai United Laboratories Co. Ltd. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These active matters are distributed across 2 distinct examiners and 2 distinct art units. This distribution indicates that the company's patenting activities are spread across different technical sub-specialties or administrative groups within the patent office.
HOWELL, THEODORE R is identified as the busiest examiner for the portfolio, with 1 pending office action currently assigned. This 1 busiest examiner pending case is part of the company's total active workload of 2 pending office actions. The involvement of 2 distinct art units and 2 distinct examiners suggests a diversified prosecution landscape relative to the 2 pending office actions, as each file is being reviewed by a different individual in a different unit. This structure requires the company to manage multiple simultaneous interactions across the Biotechnology & Pharmaceuticals sector. The data highlights a portfolio that is technically or administratively varied. Each of the 2 pending office actions is handled by a separate examiner, which may lead to different prosecution timelines.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOWELL, THEODORE R | 1 | 66.8% | +25.3% |
| CHAO, ALLEN | 1 | 55.6% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682329 | LOCAL TOPICAL FORMULATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | HOWELL, THEODORE R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682329 | LOCAL TOPICAL FORMULATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | HOWELL, THEODORE R | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18682329 | LOCAL TOPICAL FORMULATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | HOWELL, THEODORE R | 1628 | §103§112 | Non-Final OA | — | Pending | Feb 08, 2024 |
| 18263434 | ORAL PREPARATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | CHAO, ALLEN | 1622 | §103 | Final Rejection | 42d overdue | Pending | Jul 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial